XML 145 R90.htm IDEA: XBRL DOCUMENT v3.6.0.2
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Numerator:                      
Net income attributable to Biogen Idec Inc $ 649.2 $ 1,032.9 $ 1,049.8 $ 970.9 $ 831.6 $ 965.6 $ 927.3 $ 822.5 $ 3,702.8 $ 3,547.0 $ 2,934.8
Denominator:                      
Weighted average number of common shares outstanding 216.6 218.9 219.1 218.9 220.4 232.2 235.3 235.0 218.4 230.7 236.4
Effect of dilutive securities:                      
Dilutive potential common shares                 0.4 0.5 0.8
Shares used in calculating diluted earnings per share 217.0 219.4 219.4 219.3 220.8 232.6 235.7 235.6 218.8 231.2 237.2
Earnings per share (Textual)                      
Repurchase of common stock                 0.7 4.6 1.0
Stock options and employee stock purchase plan                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.1 0.1 0.1
Time-vested restricted stock units                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.2 0.3 0.5
Market stock units                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.1 0.1 0.2